Slaughter JC , Hardman JM, Kempe LG, et al: Neurocutaneous melanosis and leptomeningeal melanomatosis in children. Arch Pathol1969 ; 88:298-304.
2.
Humes RA, Roskamp J., Eisenbrey AB: Melanosis and hydrocephalus: Report of four cases. J Neurosurg1984;61:365-368.
3.
Leaney BL, Rowe PW, Klug GL: Neurocutaneous melanosis with hydrocephalus and syringomyelia. J Neurosurg1985;62:148-152.
4.
Novotny EJ, Urich H.: The coincidence of neurocutaneous melanosis and encephalofacial angiomatosis . Clin Neuropathol1986;5:246-251.
5.
Yu HS, Tsaur C., Chien CH, et al: Neurocutaneous melanosis: Electron microscopic comparison of the pigmented melanocytic nevi of skin and meningeal melanosis. J Dermatol1985; 12:267-276.
Farnell FJ, Globus JH: Primary melanoblastosis of the leptomeninges and brain. Arch Neurol Psychiatry1931;25:802-823.
13.
Kudel TA, Bingham WT, Tubman DE: Computed tomographic findings of primary malignant leptomeningeal melanoma in neurocutaneous melanosis. Am J Radiol1979 ;133:950-951.
14.
van Heuzen P., Kaiser MC, de Slegte Rgm: Neurocutaneous melanosis associated with intraspinal lipoma. Neuroradiology1989;31:349-351.
15.
Harper CG, Thomas Dgt: Neurocutaneous melanosis. J Neurol Neurosurg Psychiatry1974;37:760-763.
16.
Williams HI : Primary malignant meningeal melanoma associated with benign hairy naevi. J Pathol Bacteriol1969;99:171-174.
17.
Ellis DS, Spencer WH, Stephenson CM: Congenital neurocutaneous melanosis with metastatic orbital malignant melanoma . Ophthalmology1986;93:1639-1642.
18.
Willis RA: The hamartomatous syndromes: Their clinical, pathological and fundamental aspects. Med J Aust1965;1:827-833.
19.
Bamborschke S., Ebhardt G., Szelies-Stock B., et al: Review and case report: Primary melanoblastosis of the leptomeninges. Clin Neuropathol1985 ;4:47-55.
20.
Kaplan AM, Itabashi HH, Hanelin LG, Lu AT: Neurocutaneous melanosis with malignant leptomeningeal melanoma. Arch Neurol1975; 32:669-671.
21.
Reyes-Mugica M., Chou P., Byrd S., et al: Neuromelanocytic proliferations in the central nervous system of children. Cancer1993; 72:2277-2285.
Kadonga JN, Barkovich AJ, Edwards MS, Frieden IJ: Neurocutaneous melanosis in association with the Dandy-Walker complex . Pediatr Dermatol1992;9:137-143.
27.
Osborn AG: Diagnostic Neuroradiology. St Louis, Mosby, 1994 pp 59-71.
28.
Grossman RI, Yousem DM: Neuroradiology, the Requisites. St Louis, Mosby, 1994, pp 259-261.
29.
Shaw CM, Alvord EC: Hydrocephalus, in Duckett S (ed): Pediatric Neuropathology. Baltimore, Williams & Wilkins, 1995, pp 152-159.
30.
Salm R.: Primary malignant melanoma of the cerebellum. J Pathol Bacteriol1967;94:196-199.
31.
Kadonga JN, Frieden IJ: Neurocutaneous melanosis: Definition and review of the literature . J Am Acad Dermatol1991;24:747-755.
32.
Voorhess ML : Urinary excretion of DOPA and metabolites by patients with melanoma. Cancer1970;26:146-149.
33.
Muskiet Faj , Stratingh MC, Stob GJ, Wolthers BG: Simultaneous determination of the four major catecholamine metabolites and estimation of a serotonin metabolite in urine by capillary gas chromatography of their tert-butyldimethylsilyl derivatives . Clin Chem1981; 27:223-227.
34.
Ito S., Kato T., Maruta K., et al: "Total" acidic metabolites of catecholamines in urine as determined by hydrolysis with hydriatic acid and liquid chromatography: Application to patients with neuroblastoma and melanoma. Clin Chem1985;31:1185-1188.
35.
Morgan LR, Lolley D., Maddox B., et al: Urine homovanillic acid and tissue DOPA oxidase in patients with melanoma. Cancer1974;33: 1601-1606.
36.
Trapeznikov NN, Raushenbakh MO, Ivanova VD, Yavorsky W.: Clinical evaluation of a method of quantitative determination of homovanillic acid for the estimation of degree of tumor dissemination process in melanoma of the skin. Cancer1975 ;36:2064-2068.
Bast RC, Klug TL, St John E., et al: A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med1983;309:883-887.
39.
Pittaway DE , Fayez A.: SerumCA-125 antigen levels increase during menses. Am J Obstet Gynecol1987;156:75-76.
40.
Niloff JM, Knapp RC, Schaetzl E., et al: CA125 antigen levels in obstetric and gynecologic patients. Obstet Gynecol1984;64:703-707.
41.
Ruibal A., Encabo G., Capdevila JA, et al: Comportamiento delCA 125 serico en pacientes hepatopatas. Med Clin (Barc)1984 ;82:560.
42.
Vasilev SA, Schlaerth JB, Campeau J., et al: SerumCA 125 levels in preoperative evaluation of pelvic masses. Obstet Gynecol1988;71:751-755.
43.
Bast RC, Feeney M., Lazarus H., et al: Reactivity of a monoclonal antibody with human ovarian carcinoma . J Clin Invest1981;68: 1331-1337.